Pharmaceutical Industry Reports Sucralfate Market | Page 2

REPORT DESCRIPTION
Sucralfate Market – Overview
Sucralfate is the generic form of the brand-name drug, Carafate. It is a prescription medicine used to treat
ulcers of the upper gastrointestinal tract, peptic ulcer disease, and to prevent reoccurrence of ulcers.
Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It
forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes
and helps ulcers to heal more quickly.
Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat,
which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and
corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock,
sepsis, and burns), and inflammatory bowel disease.
Increasing research and development activities for discovering new medicine using sucralfate is expected
to propel growth of the sucralfate market. For instance, according to the American Broncho
Esophagological Association report in April 2018, use of sucralfate along with honey aids in treatment of
esophageal injury in infants and children.
© Coherent market Insights. All Rights Reserved